Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syria Laperche

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Transfusion|March 28, 2008
Antigen-antibody combination assays for blood donor screening: weighing the advantages and costsSyria Laperche
Transfusion|July 19, 2012
Multinational assessment of blood-borne virus testing and transfusion safety on the African continentSyria Laperche,
Frontiers in Medicine|March 9, 2018
Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?Daniel Candotti, Syria Laperche
The New England Journal of Medicine|November 24, 2004
HIV-1 and HCV infections among antibody-negative blood donorsSyria Laperche, Josiane Pillonel, Patrick Herve
Transfusion|August 19, 2014
Safety measures to prevent hepatitis E virus transmission by blood transfusionSyria Laperche, Jacques Izopet, Jean-Jacques Lefrère
Transfusion|January 11, 2008
Repository of blood samples from recipients of red blood cell transfusions in FranceJean-Jacques Lefrère, Syria Laperche, Robert Girot
Transfusion|July 28, 2007
Should cellular therapy products be tested for human herpesvirus 8?Jean-Jacques Lefrère, Nicolas Guillaume, Syria Laperche
Hepatology (Baltimore, Md.)|March 5, 2011
Genotype 4 hepatitis C virus: beware of false-negative RNA detectionSepideh Akhavan, Christophe Ronsin, Syria Laperche, et al.
Vox Sanguinis|August 21, 2018
Updated characteristics of blood services, donors and blood products in 11 French-speaking African countriesClaude T Tagny, Syria Laperche, Edward L Murphy, et al.
Journal of Clinical Microbiology|September 1, 2011
Revision of interpretation criteria of the INNO-LiPA HBV genotyping assayJoke Doutreloigne, Elien Van Hecke, Mélanie Mercier, et al.
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Transfusion|March 28, 2008
Antigen-antibody combination assays for blood donor screening: weighing the advantages and costsSyria Laperche
Transfusion|July 19, 2012
Multinational assessment of blood-borne virus testing and transfusion safety on the African continentSyria Laperche,
Frontiers in Medicine|March 9, 2018
Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?Daniel Candotti, Syria Laperche
The New England Journal of Medicine|November 24, 2004
HIV-1 and HCV infections among antibody-negative blood donorsSyria Laperche, Josiane Pillonel, Patrick Herve
Transfusion|August 19, 2014
Safety measures to prevent hepatitis E virus transmission by blood transfusionSyria Laperche, Jacques Izopet, Jean-Jacques Lefrère
Transfusion|January 11, 2008
Repository of blood samples from recipients of red blood cell transfusions in FranceJean-Jacques Lefrère, Syria Laperche, Robert Girot
Transfusion|July 28, 2007
Should cellular therapy products be tested for human herpesvirus 8?Jean-Jacques Lefrère, Nicolas Guillaume, Syria Laperche
Hepatology (Baltimore, Md.)|March 5, 2011
Genotype 4 hepatitis C virus: beware of false-negative RNA detectionSepideh Akhavan, Christophe Ronsin, Syria Laperche, et al.
Vox Sanguinis|August 21, 2018
Updated characteristics of blood services, donors and blood products in 11 French-speaking African countriesClaude T Tagny, Syria Laperche, Edward L Murphy, et al.
Journal of Clinical Microbiology|September 1, 2011
Revision of interpretation criteria of the INNO-LiPA HBV genotyping assayJoke Doutreloigne, Elien Van Hecke, Mélanie Mercier, et al.
Pageof 15